Introduction
Thiomarinol A 1 ( Fig. 1) , is the major metabolite produced by the marine bacterium Pseudoalteromonas sp. SANK 73390, along with minor analogues B to G (2 to 7). [1] [2] [3] They display antibiotic activity against both Gram-negative and Gram-positive bacteria, and have particularly potent activity against methicillin-resistant Staphylococcus aureus (MRSA). They are unusual in being hybrid antibiotics, effectively two separate antibiotic classes in one molecule, and biosynthetically can be regarded as comprising three main elements: a highly functionalised polyketide-derived acid, which is esteried by a hydroxy fatty acid, which itself forms an amide with the bicyclic amino acidderived pyrrothine. The main carbon skeleton of the thiomarinols is very closely related to that of mupirocin, an important antibiotic used clinically against MRSA. 4 Mupirocin consists of a mixture of pseudomonic acids (PA A-C, 8 to 10), [5] [6] [7] with PA-A comprising ca. 95% of the mixture. The major differences in thiomarinol A are the replacement of the 9-hydroxynonanoic acid moiety in the PAs with 8-hydroxyoctanoate in the thiomarinols, the presence of an extra 4-hydroxyl group, the lack of the 10,11-epoxide and the pyrrothine. Many pyrrothine natural products themselves display antibiotic activity, e.g. holomycin 11, N-propionylholothin 12, thiolutin 13, and aureothricin 14. [8] [9] [10] Stable isotope labelling studies were used to conrm the origins of all of the atoms in pseudomonic acid A and were consistent with a polyketide/fatty acid origin.
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This was subsequently conrmed by isolation of the biosynthetic gene cluster 13 which revealed that mupirocin was one of the rst members of what is now known to comprise an increasingly large number of biologically active compounds. These are most oen from diverse and unusual bacterial sources and are produced via trans-AT modular PKSs that have evolved independently from other modular systems.
14 The main identifying feature of these systems is the lack of an integral acyl transferase (AT) domain in each chain extension module, this function being supplied "in trans" to each module by separately encoded mono-(or di-) functional ATs. In addition they show many other unusual features including extensive involvement of other trans acting enzymes during polyketide assembly. In particular b-branches are introduced onto b-keto-thiol ester intermediates by a cassette of enzymes that include an HMG CoA synthase (HMGS) analogue using chemistry similar to that involved in mevalonate formation in terpene biosynthesis. 15 The biosynthesis of the pyrrothine class of natural products has not been studied in detail, although cysteine has been implicated as a precursor via radioisotope labelling studies. 16 We have recently identied the thiomarinol (tml) biosynthetic gene cluster via full genome sequencing of SANK 73390. It is contained on a 97 kb plasmid consisting almost entirely of the thiomarinol biosynthetic genes. 17 These consist of trans-AT PKSs (tmpA, C and D), a putative FAS (tmpB) and associated tailoring and resistance genes (tmlA-Z) with high homology to the mupirocin (mup) cluster (Fig. S1 , ESI †). A non-ribosomal peptide synthetase (NRPS) linked to a set of tailoring enzymes (holA-H) is also present similar to that recently shown to control holomycin biosynthesis in Streptomyces clavuligerus. 18, 19 Analysis of the WT culture and mutant strains in which the PKS and NRPS parts of the cluster had been deactivated by in-frame deletions, resulted in isolation of a number of new thiomarinol related compounds. 20 Analysis of extracts of the WT strain by reversed-phase HPLC-ESIMS led to the isolation of two additional polar metabolites which lacked the pyrrothine moiety. These were shown to be marinolic acid A 15 and the corresponding amide, marinolic amide 16. Similar analysis of the DNRPS mutant strain showed, as expected, that no pyrrothine containing compounds were produced, the major thiomarinol metabolite being marinolic acid A, but no amide 16. Two minor metabolites were isolated: marinolic acid A 6 17 and A 4 18 in which the octanoate moiety on marinolic acid A has been replaced by hexanoate and butanoate respectively. Re-examination of the WT extracts revealed trace amounts of 17. A number of new acyl-pyrrothine containing compounds were also isolated. On the basis of their similarity to metabolites previously isolated [21] [22] [23] from Xenorhabdus spp, they were designated as xenorhabdins 8-13 (19-25) respectively (Fig. 2) .
We now report stable isotope labelling and other feeding experiments with WT and mutant strains of Pseudoalteromonas which conrm the origins of all of the atoms in thiomarinol, provide a rationalisation for the occurrence of the minor related metabolites, and for the timing of pyrrothine formation and its linkage to marinolic acid. and H7 0 (to C6 0 and C5 0 ) allowing these two carbons, which are separated by 0.1 ppm, to be unambiguously assigned. In d 6 -DMSO, the 15-and 17-methyls are coincident, but they are resolved in d 4 -methanol. Prior to stable-isotope labelled precursor feeding, the production of thiomarinol A was monitored. This showed that thiomarinol production commences at around 7 hours aer the start of fermentation, reaches a maximum around 24 hours and levels then slowly decrease thereaer. The labelled precursors were therefore fed to the fermentation media ca. 7 hours aer inoculation, and the fermentation extracted aer 24 hours. The crude extract obtained was puried to give thiomarinol A, which was then analysed by 13 C NMR to determine the extent and positions of 13 Fig. S12 †) . another trans-AT metabolite of Bacillus amyloliquefaciens, also contains an oxo-acyl CoA reductase encoded by difE which as in mupirocin/thiomarinol is grouped with an acyl CoA synthetase and an ACP (difD and difC). In addition there is an adjacent kinase (difB) which would be suitable for catalysing dehydration of 3-hydroxypropionate to produce the acryl thiol ester required to prime difficidin chain elongation. The retention of 18 O label at C1 0 of thiomarinol A is slightly less than half that at the other acetate-oxygen bearing positions. This is consistent with C1 0 existing as the free carboxylate, resulting in randomisation of the label between both carboxylate oxygens, before ligation via an amide bond to the pyrrothine. Analysis of the structure of the pyrrothine moiety of thiomarinol suggest that it is formed via two molecules of cysteine. To gain evidence for this proposal, [2- that the pyrrothine is indeed cysteine, and therefore NRPS, derived (Scheme 2). The biosynthetic gene cluster for holomycin biosynthesis in Streptomyces clavuligerus has been isolated and a pathway from cysteine proposed. This pathway involves initial dipeptide formation followed by a series of oxidative cyclisations, the nal step being acetylation of the free pyrrothine. 18 To prove that the pyrrothine moiety in thiomarinol is assembled and then incorporated as an intact unit rather than being assembled on marinolic acid, pyrrothine was synthesised as previously described 27 and fed to the DNRPS mutant strain of SANK 73390. The mutant was prepared by a deletion in the holA gene encoding the amino acid activation domain which, from sequence analysis of the active site, is predicted to selectively activate cysteine. As indicated above, the DNRPS mutant normally produces mainly marinolic acid. When cultures were supplemented with pyrrothine, the normal WT phenotype was restored indicating that Pseudoalteromonas takes the intact pyrrothine as substrate (Scheme 3). Interestingly, the concentration of the feeds was critical, with maximum restoration of thiomarinol A production being observed at a pyrrothine concentration of 20 mg ml À1 . At concentrations of >80 mg ml À1 , no thiomarinol A was observed and production of marinolic acid was also completely inhibited (Fig. S3 , ESI †).
Results and discussion

Novel acyl pyrrothines via mutasynthesis
Previous studies have shown that when TmlU, a putative amide ligase is knocked out, the mutant strain produces no thiomarinol but does produce marinolic acid and the full set of xenorhabdins. 20 The HolE analogue, ORF3483, from the holomycin cluster in S. clavuligerus has been expressed and puried and it has been shown 18 to act as an acyl transferase capable of transferring acetyl and longer acyl groups to pyrrothine. Thus it appears that the thiomarinol cluster has two ligases, TmlU which forms the amide in thiomarinol, and HolE which links pyrrothine to a wide range of acyl CoAs available in Pseudoalteromonas to produce the xenorhabdins.
To test if HolE can also transfer a range of non-endogenous substrates, various short, medium and long chain fatty acids and others with u-functionalized side chains, e.g. hydroxyl, amino, carboxyl and phenyl were fed to the DPKS mutant (Scheme 4). Some of these were incorporated with varying efficiencies, presumably aer conversion to their respective CoA esters, sometimes aer catabolic chain shortening to give 19 and the novel acyl-pyrrothines 26-30.
The biosynthesis of thiomarinol A and related metabolites
The isolation of the minor metabolites 15-18 from both WT and mutant strains and the incorporation of isotopically labelled substrates can be rationalised as shown in Scheme 5. Marinolic acid A 15 is produced by the DNRPS and DTmlU mutants, and is present in trace amounts in the WT which suggests that it is both a genuine biosynthetic product and intermediate in its own right and is not produced as an artefact, e.g. as a degradation product of thiomarinol A. The intermediacy of marinolic acid 15 was conrmed by feeding it to the DPKS mutant whereupon, thiomarinol production was restored (Fig. S19 †) . The amide 16 on the other hand was only seen in the WT cultures which suggests that it is formed by degradation of thiomarinol A, and is not formed by, e.g. amidation of marinolic acid. This was further evidenced by feeding thiomarinol A to the DPKS mutant when the presence of both marinolic acid and marinolic amide in the crude extract could be observed by LCMS. This suggests that the amide is indeed a degradation product of thiomarinol.
The isolation of truncated metabolites marinolic acids A 4 and A 6 , is consistent with the isotope labelling studies which suggest that a C 4 intermediate is added to the product of the PKS, e.g. by trans-esterication. This would then be elongated to Scheme 3 Feeding pyrrothine to the NRPS mutant gives thiomarinol A.
Scheme 4 Novel acyl-pyrrothines generated using the DNRPS mutant.
give an enzyme bound hexanoate analogue which would be further elongated to give the completed octanoate side chain. In the absence of the pyrrothine in the DNRPS mutant they would be released either by enzymatic or spontaneous hydrolysis as marinolic acids. We have previously shown that release of assembly intermediates occurs when ux of intermediates along the normal mupirocin pathway is impaired by a range of targeted mutations of trans-acting and other tailoring genes.
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Similar mechanisms would allow leakage of marinolic acids A 4 and A 6 into the medium. It is signicant that this appears to be more pronounced in the mutant than the WT. Truncated forms of mupirocin and related metabolites with C 7 and C 5 hydroxy acids have also been observed in both mutant strains and when the quorum sensing regulation mechanism has been manipulated to increase mupirocin production.
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Conclusions
Using a combination of genetic and isotopic labelling studies, evidence has been presented for a mixed PKS-NRPS biosynthetic pathway to the antibiotic thiomarinol A in Pseudoalteromonas sp. SANK 73390. Particularly interesting features of the pathway include assembly of the 8-hydroxyoctanoic acid side-chain, which is generated via chain extension of a C 4 precursor (4-hydroxybutyrate), and both marinolic acids A 4 18 and A 6 17 have been isolated as minor metabolites from both wild-type and the DNRPS mutant. There was a good incorporation of [ 13 C]cystine into thiomarinol A and feeding studies with synthetic pyrrothine to the DNRPS mutant are in accord with heterocycle assembly (HolA-D, F-H) prior to intact incorporation into thiomarinol A (TmlU). A further minor metabolite, marinolic amide 16, present in wildtype but not the DNRPS mutant, is a degradation product of thiomarinol. Isotopic labelling studies indicate that the biosynthesis of the C1-C17 fragment is analogous to that of pseudomonic acid, a trans-AT modular PKS pathway with many fascinating and, as yet, unexplained features and these studies lay the foundation for a further understanding of the pathways to these compounds.
